Andre E. Owens

Securities Regulation

4.0 (1 reviews)

Washington, District of Columbia

37+ years experience

Wilmer Cutler Pickering Hale and Dorr LLP

Updated: Jan 03, 2026

Contact Information

202-663-6000

https://www.wilmerhale.com/en/people/andre-owens

2100 Pennsylvania Avenue NW, Washington, DC 20036

Create an account to contact this attorney

Bio

Andre E. Owens is a top attorney recognized by Best Lawyers in the practice area(s) of Securities Regulation.Andre E., who practices law in Washington, District of Columbia, has been recognized since 2022. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Andre E. is held by other top lawyers in the same geographic and legal practice area. Andre E. Owens is a top attorney recognized by Best Lawyers in the practice area(s) of Securities Regulation.Andre E., who practices law in Washington, District of Columbia, has been recognized since 2022. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Andre E. is held by other top lawyers in the same geographic and legal practice area. Andre E. is held by other top lawyers in the same geographic and legal practice area.

Practice Areas

Securities Regulation

Awards & Recognition

Recognized: Securities Regulation
Practice Area: FDA Law
Practice Area: FinTech Practice
Practice Area: Securities / Capital Markets Law

Recognized in Best Lawyers since 2022

Education

Harvard University, J.D., graduated 1988

Get Directions on Google Maps

Reviews

Brenda Kelly

2 weeks ago

Expert Guidance Through a Complex FinTech Regulatory Maze

Our company, a mid-stage FinTech startup, faced a daunting and multifaceted regulatory challenge involving both the SEC and evolving FDA digital health guidelines for our new product. We needed counsel who could navigate this intersection with authority. Engaging Andre Owens at WilmerHale was a decisive move. His deep, 37-year foundation in securities regulation, combined with his specific recognition in FinTech and FDA law, provided immediate credibility. He didn't just give us legal answers; he mapped the strategic landscape, explaining the motivations of different agencies and helping us structure our compliance framework proactively. His team's work product was impeccable, clearly informed by his Harvard Law pedigree and decades of high-stakes practice in D.C. While the overall value was exceptional, there were occasional periods where direct communication slowed, likely due to his demanding caseload. A slightly more predictable response cadence would be the only suggestion for improvement. For any business operating at the nexus of technology and heavy regulation, Andre's seasoned judgment is an invaluable asset.